Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 10490 records

$50,000.00

Feb 4, 2021

For-profit organization

Agreement:

Multi-language Support for the Winterlight Assessment App

Agreement Number:

969026

Duration: from Feb 4, 2021 to Dec 31, 2021
Description:

Given the number of
clinical trial sites in different countries across the world, the following languages were identified as top-priorities from
the business perspective: 1) Spanish, 2) French, 3) German.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Toronto, Ontario, CA M4Y 1V8

$50,000.00

Feb 1, 2021

For-profit organization

Agreement:

Powered wheelchair training and assessment platform

Agreement Number:

965533

Duration: from Feb 1, 2021 to Aug 31, 2021
Description:

It will provide new training opportunities to those who are learning how to drive by offering driving insights to therapists and caregivers. It can also help clinical researchers studying various aspects of wheelchair use such as activity and participation.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Toronto, Ontario, CA M5S 1A7

$2,282,176.00

Feb 1, 2021

For-profit organization

Agreement:

COVID-19-Treatment for lung injury

Agreement Number:

966019

Duration: from Feb 1, 2021 to May 31, 2023
Description:

This project represents important steps of the full non-clinical FB100 development program which will lead to clinical trials in early 2022.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Toronto, Ontario, CA M5L 1A9

$303,341.00

Jan 21, 2021

Academia

Agreement:

Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines

Agreement Number:

964417

Duration: from Jan 21, 2021 to Mar 31, 2022
Description:

This research will pave the way toward a human clinical trial.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Guelph, Ontario, CA N1G 2W1

$303,341.00

Jan 21, 2021

Academia

Agreement:

Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines

Agreement Number:

964417

Duration: from Jan 21, 2021 to Jan 17, 2022
Description:

This research will pave the way toward a human clinical trial.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Guelph, Ontario, CA N1G 2W1

$342,500.00

Jan 20, 2021
Agreement:

217056

Agreement Number:

217056

Duration: from Jan 20, 2021 to Oct 31, 2021
Description:

Purchase manufacturing equipment to improve production efficiencies and product quality

Organization: Atlantic Canada Opportunities Agency
Program Name: REGI - Business Scale-up and Productivity
Location: Moncton, New Brunswick, CA E1E 4E3

Other

Agreement:

2021-HQ-000124

Agreement Number:

2021-HQ-000124

Duration: from Jan 19, 2021 to Mar 31, 2021
Description:

Not a Project (Mandated or Core Funding)

Organization: Health Canada
Program Name: Canadian Health Systems and Programs
Location: Burnaby, British Columbia, CA V3N 3R2

$10,000,000.00

Jan 19, 2021

Academia

Agreement:

816107

Agreement Number:

816107

Duration: from Jan 19, 2021 to Mar 31, 2026
Description:

The project will capitalize on the strong pipeline of health tech companies that is emerging in southwestern Ontario to connect them with an integrated suite of services ranging from mentorship and business advisory services, support for health tech product development, and access to specialized labs and clinical trial spaces at the University of Waterloo’s planned Innovation Arena and at Western University.

Organization: Federal Economic Development Agency for Southern Ontario
Program Name: Regional Innovation Ecosystem
Location: Waterloo, Ontario, CA N2L 3G1

Not-for-profit organization or charity

Agreement:

Transduced t cells for pre-clinical development of novel cd22 car-t’s

Agreement Number:

969531

Duration: from Jan 15, 2021 to Jun 30, 2021
Description:

This project build on the success of the work done over the last two years in establishing clinical grade manufacturing for both lentivirus and cell products, and in executing the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The overarching goal of the Project is to build much needed capacity in point-of-care (POC) manufacturing to support the clinical rollout of novel CAR T-cell products and other personalized cell therapy products with the addition of new POC manufacturing and clinical sites.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Vancouver, British Columbia, CA V5Z 4E6

$50,000.00

Jan 15, 2021

For-profit organization

Agreement:

Hypothesis Validation for a Point-of-care urinalysis platform for at-home metabolic monitoring

Agreement Number:

964334

Duration: from Jan 15, 2021 to May 31, 2021
Description:

Herstasis Health Inc is developing a clinical Point-of-Care urinalysis invitro medical diagnostic device.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: New Westminster, British Columbia, CA V3L 2R8